ZYUS

ZYUS is a life sciences company focused on developing and commercializing novel cannabinoid-based pain therapeutics candidates. Through rigorous scientific exploration and clinical research, ZYUS is committed to securing intellectual property protection to safeguard its innovative therapies and enhance shareholder value. ZYUS is steadfast in its pursuit of regulatory approval for non-opioid solutions, aiming for a transformative impact on patient lives.